Well you are wrong on all counts. Burgers name was mentioned as a director of Biocurex in the article.
Mr. Trent Davis, CEO, stated, "We are pleased to have Dr. Burger return to the Company's Board, of which he was a member from 2008 to 2010." From 1991-2011, he was managing director of Sovereign Ventures, LLC, a biotech investing and consulting firm. He was a director of BioCurex, Inc.,
Also 800k traded back in May for $.04 and the stock as been trading ever since. Who ever owns the patents isn't going to sit on them they will be sold off. Oncopet was a viable product and the plan was for Burger to take it to the next level and make it a point of care.
